From the Department of Pharmacology and Molecular Therapeutics (K.T., N.K., K.U., Y.H., K.K., T.K., D.S., M.J.M., T.N., S.K.-M.) and Department of Cardiovascular Medicine, Faculty of Life Science (K.T., H.O.), Kumamoto University Graduate School of Medical Sciences, Kumamoto, Japan; Research Fellowship of the Japan Society for the Promotion of Science, Tokyo, Japan (K.T.); Department of Cardiovascular Clinical and Translational Research, Kumamoto University Hospital, Kumamoto, Japan (O.Y.); Department of Neurology, Graduate School of Medicine, Mie University, Tsu, Japan (H.T.); and Laboratory of Cell Signaling, Graduate School of Pharmaceutical Sciences, and Global Center of Excellence (GCOE) Program, The University of Tokyo, Tokyo, Japan (H.I.).
Arterioscler Thromb Vasc Biol. 2014 Mar;34(3):616-25. doi: 10.1161/ATVBAHA.113.302440. Epub 2013 Dec 26.
There are currently no specific strategies for the treatment or prevention of vascular dementia. White matter lesions, a common pathology in cerebral small vessel disease, are a major cause of vascular dementia. We investigated whether apoptosis signal-regulating kinase 1 (ASK1) might be a key molecule in cerebral hypoperfusion, associated with blood-brain barrier breakdown and white matter lesions.
A mouse model of cognitive impairment was developed by inducing chronic cerebral hypoperfusion in white matter including the corpus callosum via bilateral common carotid artery stenosis (BCAS) surgery. BCAS-induced white matter lesions caused cognitive decline in C57BL/6J (wild-type) mice but not in ASK1-deficient (ASK1(-/-)) mice. Phosphorylated ASK1 increased in wild-type mouse brains, and phosphorylated p38 and tumor necrosis factor-α expression increased in corpus callosum cerebral endothelial cells after BCAS in wild-type mice but not in ASK1(-/-) mice. BCAS decreased claudin-5 expression and disrupted blood-brain barrier in the corpus callosum of wild-type but not ASK1(-/-) mice. Cerebral nitrotyrosine was increased in wild-type and ASK1(-/-) BCAS mice. Cerebral phosphorylated ASK1 did not increase in wild-type mice treated with NADPH-oxidase inhibitor. A p38 inhibitor and NADPH-oxidase inhibitor mimicked the protective effect of ASK1 deficiency against cognitive impairment. Specific ASK1 inhibitor prevented cognitive decline in BCAS mice. In vitro oxygen-glucose deprivation and tumor necrosis factor-α stimulation caused the disruption of endothelial tight junctions from wild-type mice but not ASK1(-/-) mice.
Oxidative stress-ASK1-p38 cascade plays a role in the pathogenesis of cognitive impairment, through blood-brain barrier breakdown via the disruption of endothelial tight junctions. ASK1 might be a promising therapeutic target for chronic cerebral hypoperfusion-induced cognitive impairment.
目前尚无血管性痴呆的特定治疗或预防策略。脑小血管病的常见病理学——白质病变,是血管性痴呆的主要原因。我们研究了凋亡信号调节激酶 1(ASK1)是否可能是与血脑屏障破坏和白质病变相关的脑低灌注的关键分子。
通过双侧颈总动脉狭窄(BCAS)手术诱导包括胼胝体在内的白质慢性脑低灌注,建立认知障碍的小鼠模型。BCAS 诱导的白质病变导致 C57BL/6J(野生型)小鼠认知能力下降,但 ASK1 缺陷(ASK1(-/-))小鼠没有。野生型小鼠大脑中磷酸化 ASK1 增加,BCAS 后野生型小鼠胼胝体脑内皮细胞中磷酸化 p38 和肿瘤坏死因子-α表达增加,但 ASK1(-/-)小鼠没有。BCAS 降低了野生型小鼠胼胝体中 Claudin-5 的表达并破坏了血脑屏障,但 ASK1(-/-)小鼠没有。野生型和 ASK1(-/-)BCAS 小鼠的脑硝基酪氨酸增加。野生型小鼠用 NADPH 氧化酶抑制剂处理后,脑磷酸化 ASK1 没有增加。p38 抑制剂和 NADPH 氧化酶抑制剂模拟了 ASK1 缺陷对认知障碍的保护作用。特异性 ASK1 抑制剂可预防 BCAS 小鼠的认知下降。体外氧葡萄糖剥夺和肿瘤坏死因子-α刺激导致来自野生型小鼠的内皮紧密连接破坏,但 ASK1(-/-)小鼠没有。
氧化应激-ASK1-p38 级联反应通过破坏内皮紧密连接在认知障碍的发病机制中起作用。ASK1 可能是治疗慢性脑低灌注引起的认知障碍的有希望的治疗靶点。